Global Biosimilars Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431671
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • Biocon
  • Celltrion, Inc.
  • Dr. Reddy’s Laboratories
  • Eli Lily, Inc.
  • Pfizer, Inc.
  • MORE
Biosimilars Market - Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2017 - 2025, the Biosimilars market was valued at US$ 3.52 Bn in 2016, and is expected to reach US$ 25.83 Bn by 2025, expanding at a CAGR of 23.1% from 2017 to 2025.

Market Insights

Biosimilars are the products approved in a country which has an abbreviated approval process for biologic products that refer to an originator biologic in the regulatory submission. Biosimilars possess similar clinical properties like safety, potency and purity as compared to the original biological product. The currently available biosimilars treatment segment are by product and application. The product segment comprises of recombinant non-glycosylated proteins (Insulin, Filgastrim, Somatropin) recombinant glycosylated proteins (Monoclonal antibodies, Erythropoietin) and recombinant peptides (Glucagon, Calcitonin).The application segment comprises of oncology, chronic and autoimmune disease, blood disorders, growth hormone disease and infectious disease. The key factors assisting the growth of biosimilars are the increasing prevalence of chronic disease, rising aging population, patient inclination towards reduced healthcare expenditure and government initiatives to promote biosimilars for e.g. Europe Medicines Agency (EMA) has finalized the guidelines on biosimilars with its elements described in ICH (Q5E). On the other hand, high complexities involved in the manufacturing of biosimilars and the rigorous regulatory framework governing their approval in countries around the world are hindering the market growth of biosimilars.

Pipeline Analysis

Pipeline of biosimilar market comprises of (recombinant non-glycosylated proteins, recombinant glycosylated proteins and recombinant peptides). Samsung Bioepis (SB4, SB2, SB5, SB9), Sandoz (GP2015, LA-EP2006, HX575), Amgen (ABP 501, ABP 980, ABP 215), Momenta (M923, M834) etc. We have estimated sales of very specific molecules based on the above mentioned type, disease prevalence, sponsor, depicted peak sales by leading market experts and other factors.

Key Market Movements:
  • Rising prevalence of cancer and chronic disease in developed and developing countries
  • Increasing geriatric population and high public awareness in developed countries is expected to boost the biosimilars market
  • Expiry of patents of biologicals coupled with government initiatives to promote biosimilars
  • Increased patient inclination towards cost effective healthcare solutions
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • Biocon
  • Celltrion, Inc.
  • Dr. Reddy’s Laboratories
  • Eli Lily, Inc.
  • Pfizer, Inc.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Biosimilars Market Portraiture
2.2 Global Biosimilars Market, by Product, 2016 (US$ Mn)
2.3 Global Biosimilars Market, by Application 2016 (US$ Mn)
2.4 Global Biosimilars Market, by Geography, 2016 (Value %)

Chapter 3 Global Biosimilars Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rising prevalence of cancer and chronic disease and geriatric population
3.2.2 Patent expiry of biologics and government initiatives to promote biosimilars
3.3 Market Restraints
3.3.1 High complexities involved in the manufacturing of biosimilars
3.3.2 Rigorous regulatory frame work governing their approval in countries around the world
3.4 Market Opportunities
3.4.1 Cost effectiveness of biosimilars in comparison to costly biological drugs.
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Biosimilars, by Key Players

Chapter 4 Global Biosimilar Market, By Type of Product
4.1 Introduction
4.2 Recombinant non - glycosylated proteins
4.3 Recombinant glycosylated proteins
4.4 Recombinant peptides

Chapter 5 Global Biosimilar Market, By Application
5.1 Market Analysis
5.2 Oncology
5.3 Chronic and autoimmune disease
5.4 Blood disorders
5.5 Growth hormone disease
5.6 Infectious disease

Chapter 6 Global Biosimilar Market, By Geography
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Latin America
6.6 Middle East and Africa

Chapter 7 Company Profiles
7.1 Pfizer, Inc.
7.2 Sandoz International GmbH
7.3 Teva Pharmaceutical Industries Limited
7.4 Amgen Inc.
7.5 Biocon
7.6 Dr. Reddy’s Laboratories
7.7 F. Hoffman - La Roche Ltd.
7.8 Celltrion, Inc.
7.9 Samsung Bioepis
7.10 Eli Lily, Inc.

List of Figures
Fig. 1 Biosimilars Market: Research Methodology
Fig. 2 Global Biosimilars Market, by Product 2016 (US$ Mn)
Fig. 3 Global Biosimilars Market, by Application, 2016 (US$ Mn)
Fig. 4 Global Biosimilars Market, by Geography, 2016 (Value %)
Fig. 5 Attractive Investment Proposition, by Geography,2016
Fig. 6 Market Positioning of Key Biosimilars Vendors, 2016
Fig. 7 Recombinant non - glycosylated proteins Product Market, 2015 - 2025 (US$ Mn)
Fig. 8 Recombinant glycosylated proteins Product Market, 2015 - 2025 (US$ Mn)
Fig. 9 Recombinant peptides Product Market, 2015 - 2025 (US$ Mn)
Fig. 10 Oncology Application Market, 2015 - 2025 (US$ Mn)
Fig. 11 Chronic and autoimmune disease Appication Market, 2015 - 2025 (US$ Mn)
Fig. 12 Blood disorders Application Market, 2015 - 2025 (US$ Mn)
Fig. 13 Growth hormone disease Application Market, 2015 - 2025 (US$ Mn)
Fig. 14 Infectious disease Application Market, 2015 - 2025 (US$ Mn)
Fig. 15 North America Biosimilars Market, 2015 - 2025 (US$ Mn)
Fig. 16 Europe Biosimilars Market, 2015 - 2025 (US$ Mn)
Fig. 17 Asia-Pacific Biosimilars Market, 2015 - 2025 (US$ Mn)
Fig. 18 Latin America Biosimilars Market, 2015 - 2025 (US$ Mn)
Fig. 19 Middle East and Africa Biosimilars Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Biosimilars Market, By Product, 2015-2025 (US$ Mn)
Table 2 Global Biosimilars Market, By Application, 2015-2025 (US$ Mn)
Table 3 Global Biosimilars Market, By Geography, 2015 - 2025 (US$ Mn)
Table 4 Pfizer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 5 Sandoz International GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 6 Teva pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 7 Amgen Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 8 Biocon: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 9 Dr. Reddy’s Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 10 F. Hoffman - La Roche Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 11 Celltrion, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 12 Samsung Bioepis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Table 13 Eli Lily, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Key Industries Served, SCOT Analysis, Recent Developments)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Pfizer, Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Limited
  • Amgen Inc.
  • Biocon
  • Dr. Reddy’s Laboratories
  • F. Hoffman - La Roche Ltd.
  • Celltrion, Inc.
  • Samsung Bioepis
  • Eli Lily, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll